secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001104659-24-098971
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Entero Therapeutics receives Nasdaq bid price deficiency notice; 180 days to cure
--------------------------------------------------------------------------------

- Nasdaq notified Entero on Sept 6, 2024 that common stock failed minimum $1.00 bid price for 30 consecutive business days.
- Company has until March 5, 2025 to regain compliance by closing at $1.00 for 10 consecutive business days.
- If not compliant, Nasdaq may grant second 180-day period if other listing standards met; otherwise delisting possible.
- Company intends to monitor bid price and seek compliance; no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924098971/0001104659-24-098971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465924098971/tm2423832d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-098971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer